British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in a bid to boost sales in its largest market.

AstraZeneca on Monday announced plans to invest $50 billion in its US operations by 2030, a sweeping commitment that includes ...

US President Donald Trump has threatened to impose tariffs of up to 20% on drug imports to boost manufacturing in America and ...

The move is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry. Read more at ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...

AstraZeneca ( AZN) said it is investing $50 billion in U.S. manufacturing by 2030, following the lead of big pharma peers ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

WASHINGTON (Reuters) -AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by ...

Nuevo León continues to attract investment to its auto sector, but some companies are now skipping investment announcements, ...

Brazil's Supreme Court Justice Alexandre de Moraes approved an investigation into possible insider trading linked to the announcement of U.S. tariffs on Brazilian imports. The probe is part of a ...

April 9: Trump's higher "reciprocal tariffs" begin just after midnight. Hours later, the president says he is issuing a 90-day pause on those duties, except for China. Trump raises tariffs on Chinese ...

Third round of Ukraine-Russia peace talks set for July 23, Zelensky says * US, Germany agree to deliver 5 Patriot air defense ...